esophageal cancer

Open Access
Nivolumab Rechallenge After Immune-related Adverse Events in Patients With Unresectable Advanced or Recurrent Esophageal Cancer
KOHDAI UENO, KUNIHITO SUZUKI, KATSUMASA SAITO, HAJIME SHINOHARA and AKINORI MIURA

In Vivo March 2024, 38 (2) 794-799; DOI: https://doi.org/10.21873/invivo.13503
Open Access
Survival Predictors Before Preoperative Adjuvant Chemotherapy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
ITARU HASHIMOTO, KAZUKI KANO, HIDEAKI SUEMATSU, TAKANOBU YAMADA, HAYATO WATANABE, KYOHEI KANEMATSU, SHINSUKE NAGASAWA, TORU AOYAMA, TAKASHI OGATA, YASUSHI RINO, AYA SAITO and TAKASHI OSHIMA

In Vivo March 2024, 38 (2) 881-889; DOI: https://doi.org/10.21873/invivo.13514
Open Access
Clinical Significance of Prealbumin Level Measurement Before Neoadjuvant Chemotherapy in Elderly Patients With Locally Advanced Esophageal Cancer
HIDEAKI SUEMATSU, TAKANOBU YAMADA, SHIZUNE ONUMA, ITARU HASHIMOTO, KYOHEI KANEMATSU, SHINSUKE NAGASAWA, TORU AOYAMA, TAKASHI OGATA, YASUSHI RINO, AYA SAITO and TAKASHI OSHIMA

In Vivo January 2024, 38 (1) 334-340; DOI: https://doi.org/10.21873/invivo.13443
Open Access
Influence of the Oral Health Assessment Tool Score on Survival of Patients With Esophageal Cancer
HIROSHI TAMAGAWA, AYAKO TAMAGAWA, TORU AOYAMA, ITARU HASHIMOTO, YUKIO MAEZAWA, KENTARO HARA, AYA KATO, NATSUMI KAMIYA, KAZUKI OTANI, MASAKATSU NUMATA, KEISUKE KAZAMA, JYUNYA MORITA, MIE TANABE, SHIZUNE ONUMA, HARUHIKO CHO, SHO SAWAZAKI, TAKASHI OHSHIMA, NORIO YUKAWA, KENJI MITSUDO, AYA SAITO and YASUSHI RINO

In Vivo September 2023, 37 (5) 2253-2259; DOI: https://doi.org/10.21873/invivo.13327
Open Access
Adverse Events in Patients With Esophageal Cancer Treated With Nivolumab in Combination With Radiotherapy
YASUSHI RINO, TORU AOYAMA, YUKIO MAEZAWA, KAZUKI KANO, MIHWA JU, HIROSHI TAMAGAWA, SHO SAWAZAKI, KEISUKE KAZAMA, HARUKA KANAI, TSUTOMU SATO, AYA SAITO and NORIO YUKAWA

In Vivo July 2023, 37 (4) 1760-1764; DOI: https://doi.org/10.21873/invivo.13264
Open Access
Clinical Impact of Proton Beam Therapy for Postoperative Lymph Node Oligorecurrence of Esophageal Cancer
YUICHI HIROSHIMA, HITOSHI ISHIKAWA, TAISUKE SUMIYA, MOTOHIRO MURAKAMI, MASATOSHI NAKAMURA, TOSHIKI ISHIDA, KOICHI OGAWA, KATSUJI HISAKURA, MASASHI MIZUMOTO, TATSUYA ODA, TOSHIYUKI OKUMURA and HIDEYUKI SAKURAI

In Vivo May 2023, 37 (3) 1253-1259; DOI: https://doi.org/10.21873/invivo.13202
Open Access
Carcinogen 4-Nitroquinoline Oxide (4-NQO) Induces Oncostatin-M (OSM) in Esophageal Cells
AMITAVA MUKHERJEE, MICHAEL W. EPPERLY, RENEE FISHER, DONNA SHIELDS, WEN HOU, ARJUN PENNATHUR, JAMES LUKETICH, HONG WANG and JOEL S. GREENBERGER

In Vivo March 2023, 37 (2) 506-518; DOI: https://doi.org/10.21873/invivo.13108
Open Access
Association Between CYP1A1 Polymorphisms and Esophageal Cancer Susceptibility: A Case-control Study
ZEHRA KAYA and SELVA GURSOY

In Vivo March 2023, 37 (2) 868-878; DOI: https://doi.org/10.21873/invivo.13155
Open Access
Usefulness of Nutrition and Inflammation Assessment Tools in Esophageal Cancer Treatment
TORU AOYAMA, KEISUKE KAZAMA, YUKIO MAEZAWA and KENTARO HARA

In Vivo January 2023, 37 (1) 22-35; DOI: https://doi.org/10.21873/invivo.13051
Open Access
Albumin and Neutrophil-to-Lymphocyte Ratio Score in Neoadjuvant Concurrent Chemoradiotherapy for Esophageal Cancer: Comparison With Prognostic Nutritional Index
WILLIAM HARRISON HSUEH, SHUN-WEN HSUEH, KUN-YUN YEH, YU-SHIN HUNG, MING-MO HO, SHINN-YN LIN, CHEN-KAN TSENG, CHIA-YEN HUNG and WEN-CHI CHOU

In Vivo September 2022, 36 (5) 2400-2408; DOI: https://doi.org/10.21873/invivo.12973

Main menu

User menu

Search

esophageal cancer

Pages